Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026)

Neogen's (NEOG) quarterly Liabilities and Shareholders Equity came in at $3.4 billion in Q1 2026, up 875.89% year-on-year from $344.2 million in Q1 2025, and little changed quarter-over-quarter from $3.4 billion in Q4 2025.

Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Neogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.4 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 875.89% year-over-year to $3.4 billion in Q1 2026; TTM through Feb 2026 was $13.5 billion, a 48.97% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 24.29% from the prior year.
  • Liabilities and Shareholders Equity was little changed at $3.4 billion in Q1 2026 per NEOG's latest filing, from $3.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $4.6 billion in Q4 2023 and bottomed at $140.2 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $3.4 billion (2025), against an average of $3.1 billion.
  • Across the five-year window, Liabilities and Shareholders Equity slumped 96.95% in 2024 and jumped 2296.01% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $4.6 billion in 2022, then climbed by 0.86% to $4.6 billion in 2023, then slumped by 96.95% to $140.2 million in 2024, then soared by 2296.01% to $3.4 billion in 2025, then dropped by 0.03% to $3.4 billion in 2026.
  • Per Business Quant, the three latest NEOG Liabilities and Shareholders Equity figures stand at $3.4 billion (Q1 2026), $3.4 billion (Q4 2025), and $3.4 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 37.13 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 6.63 Bn
8 Smith & Nephew 26.77 Bn 26.20 Bn - 10.46 Bn
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn 31.92 Bn
10 Neogen 2.07 Bn 1.91 Bn 99.00 Mn 3.36 Bn

Historic Data

Download Data
DateValue
Feb 28, 2026 3.36 Bn
Nov 30, 2025 3.36 Bn
Aug 31, 2025 3.38 Bn
May 31, 2025 3.44 Bn
Feb 28, 2025 344.20 Mn
Nov 30, 2024 140.23 Mn
Aug 31, 2024 4.06 Bn
May 31, 2024 4.55 Bn
Feb 29, 2024 4.58 Bn
Nov 30, 2023 4.60 Bn
Aug 31, 2023 4.56 Bn
May 31, 2023 4.55 Bn
Feb 28, 2023 4.51 Bn
Nov 30, 2022 4.56 Bn
Aug 31, 2022 977.41 Mn
May 31, 2022 992.93 Mn
Feb 28, 2022 981.21 Mn
Nov 30, 2021 967.93 Mn
Aug 31, 2021 932.11 Mn
May 31, 2021 920.19 Mn